Haleon, the maker of Robitussin, has issued a voluntary recall of eight lots of three varieties of its cough medicines due to microbial contamination.
The company announced the recall Jan. 24. The following products were affected: one lot of Robitussin Honey CF Max Day Adult, five lots of Robitussin Honey CF Max Day Adult and two lots of RobitussinHoney CF MAX NT Adult.
Haleon said it has not received reports of adverse events related to the affected products and is in the process of notifying distributors and customers. Customers who purchased the products listed should stop use immediately, the company said.
"In immunocompromised individuals, the use of the affected product could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection," Haleon said in the recall notice published by the FDA. "In non-immunocompromised consumers, the population most likely to use the product, life-threatening infections are not likely to occur. However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out."
View the affected lot numbers and full notice here.